Works matching IS 02698811 AND DT 2024 AND VI 38

Results: 111
    1

    ICPN meeting abstracts.

    Published in:
    Journal of Psychopharmacology, 2024, v. 38, p. 5, doi. 10.1177/02698811241300036
    Publication type:
    Article
    2
    3

    Amygdala activity after subchronic escitalopram administration in healthy volunteers: A pharmaco-functional magnetic resonance imaging study.

    Published in:
    Journal of Psychopharmacology, 2024, v. 38, n. 12, p. 1071, doi. 10.1177/02698811241286773
    By:
    • Lukow, Paulina B;
    • Lowther, Millie;
    • Pike, Alexandra C;
    • Yamamori, Yumeya;
    • Chavanne, Alice V;
    • Gormley, Siobhan;
    • Aylward, Jessica;
    • McCloud, Tayla;
    • Goble, Talya;
    • Rodriguez-Sanchez, Julia;
    • Tuominen, Ella W;
    • Buehler, Sarah K;
    • Kirk, Peter;
    • Robinson, Oliver J
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Blackcurrant (Ribes nigrum L.) improves cholinergic signaling and protects against chronic Scopolamine-induced memory impairment in mice.

    Published in:
    Journal of Psychopharmacology, 2024, v. 38, n. 12, p. 1170, doi. 10.1177/02698811241273776
    By:
    • da Costa, Pauline;
    • Schetinger, Maria Rosa C;
    • Baldissarelli, Jucimara;
    • Stefanello, Naiara;
    • Lopes, Thauan F;
    • Reichert, Karine P;
    • Assmann, Charles E;
    • Bottari, Nathieli B;
    • Miron, Vanessa V;
    • Vargas, Fermina Francesca A;
    • Gutierres, Jessié M;
    • da Cruz, Ivana Beatrice M;
    • Morsch, Vera Maria
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers.

    Published in:
    Journal of Psychopharmacology, 2024, v. 38, n. 10, p. 911, doi. 10.1177/02698811241273772
    By:
    • Ables, Jessica L;
    • Israel, Leah;
    • Wood, Olivia;
    • Govindarajulu, Usha;
    • Fremont, Rachel T;
    • Banerjee, Ronjon;
    • Liu, Hongtao;
    • Cohen, Jeremy;
    • Wang, Peng;
    • Kumar, Kunal;
    • Lu, Geming;
    • DeVita, Robert J;
    • Garcia-Ocaña, Adolfo;
    • Murrough, James W;
    • Stewart, Andrew F
    Publication type:
    Article
    30

    Psilocybin for clinical indications: A scoping review.

    Published in:
    Journal of Psychopharmacology, 2024, v. 38, n. 10, p. 839, doi. 10.1177/02698811241269751
    By:
    • Madden, Kim;
    • Flood, Breanne;
    • Young Shing, Darren;
    • Ade-Conde, Michael;
    • Kashir, Imad;
    • Mark, Melanie;
    • MacKillop, James;
    • Bhandari, Mohit;
    • Adili, Anthony
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatin.

    Published in:
    Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 818, doi. 10.1177/02698811241267836
    By:
    • Chaudhry, Imran B;
    • Husain, Muhammad Omair;
    • Khoso, Ameer B;
    • Kiran, Tayyeba;
    • Husain, Muhammad Ishrat;
    • Qurashi, Inti;
    • Rahman, Raza Ur;
    • Mehmood, Nasir;
    • Drake, Richard;
    • Husain, Nusrat;
    • Deakin, Bill
    Publication type:
    Article
    40
    41
    42

    A framework for assessment of adverse events occurring in psychedelic-assisted therapies.

    Published in:
    Journal of Psychopharmacology, 2024, v. 38, n. 8, p. 690, doi. 10.1177/02698811241265756
    By:
    • Palitsky, Roman;
    • Kaplan, Deanna M;
    • Perna, John;
    • Bosshardt, Zachary;
    • Maples-Keller, Jessica L;
    • Levin-Aspenson, Holly F;
    • Zarrabi, Ali John;
    • Peacock, Caroline;
    • Mletzko, Tanja;
    • Rothbaum, Barbara O;
    • Raison, Charles L;
    • Grant, George H;
    • Dunlop, Boadie W
    Publication type:
    Article
    43
    44
    45
    46
    47

    Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy- N,N -dimethyltryptamine benzoate) in healthy participants.

    Published in:
    Journal of Psychopharmacology, 2024, v. 38, n. 8, p. 712, doi. 10.1177/02698811241246857
    By:
    • Rucker, James Jonathan;
    • Roberts, Claire;
    • Seynaeve, Mathieu;
    • Young, Allan H.;
    • Suttle, Ben;
    • Yamamoto, Takahiro;
    • Ermakova, Anna O.;
    • Dunbar, Fiona;
    • Wiegand, Frank
    Publication type:
    Article
    48
    49
    50